Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BTAI Bioxcel Therapeutics Inc.

盘前交易 12-19 04:41:52 EST

0.3552

-0.0349

-8.95%

最高0.3988	最低0.3500	成交量121.74万
今开0.3901	昨收0.3901	日振幅12.51%
总市值1,717万	流通市值1,430万	总股本4,835万
成交额43.91万	换手率3.02%	流通股本4,025万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BTAI","market":"US","secType":"STK","nameCN":"Bioxcel Therapeutics Inc.","latestPrice":0.3552,"timestamp":1734555600000,"preClose":0.3901,"halted":0,"volume":1217443,"delay":0,"floatShares":40252200,"shares":48348364,"eps":-1.985943,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0349,"latestTime":"12-19 04:41:52 EST","open":0.3901,"high":0.3988,"low":0.35,"amount":439098.4539061,"amplitude":0.125096,"askPrice":0.355,"askSize":200,"bidPrice":0.3062,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.985943,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"listingDate":1520485200000,"adjPreClose":0.3552,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.36,"preClose":0.3552,"latestTime":"19:57 EST","volume":59926,"amount":21576.1053,"timestamp":1734569844981},"volumeRatio":1.5171523582283324,"impliedVol":2.1998,"impliedVolPercentile":0.757},"requestUrl":"/m/hq/s/BTAI/wiki","defaultTab":"wiki","newsList":[{"id":"2490913868","title":"Bioxcel Therapeutics, Inc.盘中异动 急速拉升8.40%报0.476美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490913868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490913868?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:31","pubTimestamp":1733927462,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时31分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速上涨8.40%。截至发稿，该股报0.476美元/股，成交量4.6274万股，换手率0.10%，振幅0.00%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Synlogic, Inc.涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为365.60%、100.62%、97.27%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Synlogic, Inc.、Bioline Rx Ltd，振幅分别为7.69%、6.21%、5.03%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223103a1e66a50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223103a1e66a50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BTAI"],"gpt_icon":0},{"id":"2486038422","title":"Bioxcel Therapeutics, Inc.盘中异动 股价大跌8.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038422?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:43","pubTimestamp":1732545827,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时43分，Bioxcel Therapeutics, Inc.股票出现波动，股价急速跳水8.66%。截至发稿，该股报0.465美元/股，成交量29.0777万股，换手率0.68%，振幅-88.53%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.73%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Mural Oncology Plc涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为91.73%、72.55%、46.26%，振幅较大的相关个股有Werewolf Therapeutics, Inc.、Kodiak Sciences Inc、Jasper Therapeutics, Inc.，振幅分别为107.89%、106.46%、106.21%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224347971a8615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224347971a8615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"gpt_icon":0},{"id":"2485133293","title":"Bioxcel Therapeutics, Inc.2024财年第三财季实现净利润-13.65百万美元，同比增加72.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485133293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485133293?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:02","pubTimestamp":1732291338,"startTime":"0","endTime":"0","summary":"11月23日，Bioxcel Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-13.65百万美元，同比增加72.96%；其中营业收入为214000.00美元，同比减少37.24%，每股基本收益为-0.32美元。机构评级：截至2024年11月23日，当前有4家机构对Bioxcel Therapeutics, Inc.目标价做出预测，其中目标均价为5.00美元，其中最低目标价为1.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000242abd7b8e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000242abd7b8e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ"],"gpt_icon":0},{"id":"2485526977","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌5.36%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485526977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485526977?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:31","pubTimestamp":1732285866,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时31分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速下跌5.36%。截至发稿，该股报0.540美元/股，成交量12.5865万股，换手率0.29%，振幅0.88%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃，换手率分别为496.01%、61.67%、34.73%，振幅较大的相关个股有Exicure, Inc.、Kairos Pharma, Ltd.、Virpax Pharmaceuticals, Inc.，振幅分别为10.86%、9.19%、8.70%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223106abd79178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223106abd79178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTAI","LENZ"],"gpt_icon":0},{"id":"2484117193","title":"Bioxcel Therapeutics, Inc.盘中异动 急速下跌8.74%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484117193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484117193?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113068,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速下挫8.74%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为436.73%、117.32%、88.03%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Silexion Therapeutics Corp、Alaunos Therapeutics, Inc.，振幅分别为13.77%、13.00%、10.94%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223108971a7aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223108971a7aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"gpt_icon":0},{"id":"2484484940","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘大幅下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484484940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484484940?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:31","pubTimestamp":1732026674,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时31分，Bioxcel Therapeutics, Inc.股票出现异动，股价快速下挫5.17%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃，换手率分别为619.17%、76.59%、63.31%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Invizyne Technologies Inc.、Tff Pharmaceuticals, Inc.，振幅分别为28.79%、23.08%、22.91%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223115a245ef8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223115a245ef8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BTAI"],"gpt_icon":0},{"id":"2484467517","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌5.81%报0.535美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484467517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484467517?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:32","pubTimestamp":1731940343,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速下跌5.81%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、冠科美博、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为516.44%、200.22%、187.08%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Biomx Inc.，振幅分别为50.92%、31.28%、19.34%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223223971a727d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223223971a727d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BTAI"],"gpt_icon":0},{"id":"2483372990","title":"Bioxcel Therapeutics, Inc.盘中异动 股价大涨5.67%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372990?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681075,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Bioxcel Therapeutics, Inc.股票出现异动，股价快速拉升5.67%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2759.08%、160.65%、62.22%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Pulmatrix, Inc.，振幅分别为75.68%、42.74%、12.55%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223115a23b5bd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223115a23b5bd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","BK4139","LENZ"],"gpt_icon":0},{"id":"2483802902","title":"Bioxcel Therapeutics, Inc.盘中异动 大幅跳水5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483802902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483802902?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:41","pubTimestamp":1731595317,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时41分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速下跌5.57%。截至发稿，该股报0.585美元/股，成交量6.0234万股，换手率0.15%，振幅6.48%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pulmatrix, Inc.涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1760.02%、25.20%、17.68%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Elevai Labs, Inc.，振幅分别为75.00%、38.76%、38.46%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224157a237d7f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224157a237d7f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BTAI"],"gpt_icon":0},{"id":"2482707699","title":"BioXcel Therapeutics Inc 预计每股亏损54美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482707699","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482707699?lang=zh_cn&edition=full","pubTime":"2024-11-12 21:53","pubTimestamp":1731419609,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc 预计每股亏损54美分 - 财报前瞻BioXcel Therapeutics Inc BTAI.OQ BTAI.O将于11月14日公布截至2024年9月30日的财报，预计季度收入将有所增长。LSEG 分析师对 BioXcel Therapeutics Inc 的平均预期是每股亏损 54 美分。华尔街对 BioXcel Therapeutics Inc 的 12 个月目标价中位数为 6.00 美元，高于其最新收盘价 0.72 美元。11月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4T3MJ1EY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI"],"gpt_icon":0},{"id":"2482485039","title":"BioXcel Therapeutics Inc   预计每股亏损54美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485039","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485039?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:05","pubTimestamp":1731081924,"startTime":"0","endTime":"0","summary":"   * BioXcel Therapeutics Inc    将于11月14日公布截至2024年9月30日的财报，预计季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于康涅狄格州纽黑文的公司的营收预计将从一年前的34.1万美元增至130.6万美元，增幅为282.9%。* LSEG 分析师对 BioXcel Therapeutics Inc 的平均预期是每股亏损 54 美分。* 华尔街对 BioXcel Therapeutics Inc 的 12 个月目标价中位数为 6.00 美元，高于上一次 0.67 美元的收盘价。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","LENZ"],"gpt_icon":0},{"id":"2479881757","title":"Bioxcel Therapeutics, Inc.盘中异动 快速拉升5.50%报0.750美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479881757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479881757?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:34","pubTimestamp":1730295265,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时34分，Bioxcel Therapeutics, Inc.股票出现波动，股价大幅上涨5.50%。截至发稿，该股报0.750美元/股，成交量4.2497万股，换手率0.10%，振幅1.41%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Tharimmune, Inc.、Calcimedica, Inc.、伊克力西斯涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2019.59%、103.09%、17.37%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.，振幅分别为53.69%、17.66%、16.26%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213425a1fad2c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213425a1fad2c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"gpt_icon":0},{"id":"2477383856","title":"美国研究综述-中心空间、吉利德、Gitlab","url":"https://stock-news.laohu8.com/highlight/detail?id=2477383856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477383856?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:25","pubTimestamp":1729509951,"startTime":"0","endTime":"0","summary":"    路透10月21日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Centerspace、Gilead 和 Gitlab。* 吉利德  ：Leerink Partners将其评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。* Gitlab Inc   ：Needham将其评级从 \"持有 \"上调至 \"买入 * Liberty Energy Inc   ：花旗集团将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCB","CIVI","AXP","APA","AN","CVS","DD","UPST","DTE","FANG","LU1057294990.SGD","LU2362541513.USD","BTAI","BANF","GTLB","LU1989764664.SGD","ANAB","BKV","CCK","CSR","ACLX","AR","CAPR","ELV","DVN","BLMN","CPAY","RCUS","BWA","LU2449327464.USD","PLAY","ARRY","LNG","ALLY","CHRD","AMZN","CAKE","DDOG","BK4532","EAT","IE00BJTD4N35.SGD","IE00BWXC8680.SGD","LU0061474960.USD","NFLX","OZK","PINE","CMA","LU1267930227.SGD","AES","BSX","CTRA"],"gpt_icon":1},{"id":"2470087498","title":"Bioxcel Therapeutics, Inc.盘中异动 大幅上涨5.11%报0.562美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470087498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470087498?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:45","pubTimestamp":1727448319,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时45分，Bioxcel Therapeutics, Inc.股票出现波动，股价急速上涨5.11%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3706.03%、186.90%、115.65%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为152.50%、60.69%、51.69%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927224519a1dd1425&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927224519a1dd1425&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BTAI"],"gpt_icon":0},{"id":"2469111715","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大涨6.87%报0.616美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469111715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469111715?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:31","pubTimestamp":1727098268,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时31分，Bioxcel Therapeutics, Inc.股票出现异动，股价快速上涨6.87%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Ventyx Biosciences, Inc.涨幅较大，Black Diamond Therapeutics, Inc.、Scisparc Ltd.、Elevai Labs, Inc.较为活跃，换手率分别为24.74%、22.14%、19.49%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、Xtl生物制药、Enveric Biosciences, Inc.，振幅分别为9.26%、8.20%、5.87%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213108ab655c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213108ab655c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","BK4139","LENZ"],"gpt_icon":0},{"id":"2468557242","title":"Bioxcel Therapeutics, Inc.盘中异动 急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468557242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468557242?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:31","pubTimestamp":1726752693,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时31分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅拉升5.15%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1025.30%、350.36%、70.58%，振幅较大的相关个股有Exicure, Inc.、Autolus Therapeutics Plc、Portage Biotech Inc.，振幅分别为51.97%、11.63%、11.30%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192131339719bd61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192131339719bd61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BTAI"],"gpt_icon":0},{"id":"2467773273","title":"Bioxcel Therapeutics, Inc.盘中异动 大幅上涨5.44%报0.580美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467773273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467773273?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:41","pubTimestamp":1726234900,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日21时41分，Bioxcel Therapeutics, Inc.股票出现波动，股价大幅上涨5.44%。截至发稿，该股报0.580美元/股，成交量9869股，换手率0.02%，振幅2.69%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Immuneering Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Instil Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为690.17%、81.81%、71.13%，振幅较大的相关个股有Instil Bio, Inc.、Syros Pharmaceuticals, Inc.、Oramed Pharmaceuticals Inc.，振幅分别为23.76%、21.63%、16.10%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091321414098e3784d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091321414098e3784d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"gpt_icon":0},{"id":"2460031937","title":"Bioxcel Therapeutics, Inc.盘中异动 大幅拉升6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460031937","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460031937?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:31","pubTimestamp":1724074286,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时31分，Bioxcel Therapeutics, Inc.股票出现波动，股价急速上涨6.95%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Cingulate Inc.较为活跃，换手率分别为1849.17%、1315.10%、293.68%，振幅较大的相关个股有Theriva Biologics, Inc.、Alzamend Neuro, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为31.36%、24.51%、17.56%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819213126a1d503ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819213126a1d503ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"gpt_icon":0},{"id":"2459478603","title":"Bioxcel Therapeutics, Inc.盘中异动 股价大涨7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459478603","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459478603?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:30","pubTimestamp":1723728643,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时30分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅拉升7.32%。截至发稿，该股报0.729美元/股，成交量4766股，换手率0.01%，振幅0.00%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2128.35%、1428.94%、329.34%，振幅较大的相关个股有Celcuity Inc.、Tyra Biosciences, Inc.、Vaxart, Inc. - Common Stock，振幅分别为9.31%、5.10%、5.07%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213043a1d4703d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213043a1d4703d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTAI","LENZ"],"gpt_icon":0},{"id":"2459868474","title":"Bioxcel Therapeutics, Inc.盘中异动 快速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459868474","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459868474?lang=zh_cn&edition=full","pubTime":"2024-08-15 02:08","pubTimestamp":1723658933,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日02时08分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅下跌5.41%。截至发稿，该股报0.657美元/股，成交量22.0228万股，换手率0.54%，振幅9.19%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Unicycive Therapeutics, Inc.、Cormedix Inc.、Notable Labs, Ltd.涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为93.72%、81.18%、70.35%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815020853ab5db1e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815020853ab5db1e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioxceltherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1759},{"period":"1month","weight":-0.3876},{"period":"3month","weight":-0.4587},{"period":"6month","weight":-0.6884},{"period":"1year","weight":-0.8872},{"period":"ytd","weight":-0.8796}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bioxcel Therapeutics, Inc.于2017年3月29日成为特拉华州公司，为BioXcel的全资附属公司。 BioXcel Therapeutics，Inc.或BTI是一家临床阶段的生物制药公司，专注于药物开发，利用新型人工智能或人工智能识别神经科学和免疫肿瘤学领域的下一波药物。他们的药物再创新方法利用现有批准的药物或经临床验证的产品候选药物以及大数据和专有机器学习算法来确定新的治疗指标。他们的两个最先进的临床开发项目是BXCL501，一种a2a肾上腺素能受体激动剂右美托咪定或Dex的舌下薄膜制剂，用于急性治疗由神经和精神疾病引起的激动，和BXCL701，一种用于治疗罕见形式的前列腺癌和胰腺癌。他们在2017年12月开始使用Dex在轻度可能AD中的IV制剂的1b期药代动力学/药效学或PK / PD安全性研究，并且他们计划在精神分裂症患者中使用Dex的IV制剂开始1b期药代动力学/药效学安全性研究，他们期望在2018年下半年报告这两项研究的数据。他们还打算在2018年开始两项计划的第二阶段概念证明或PoC开放标签临床试验。他们预计，到2018年底，计划在BXCL501计划的阶段2 PoC开放标签临床试验中提供的数据读数将可用。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.129318},{"month":2,"riseRate":0.833333,"avgChangeRate":0.365471},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.136546},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.016546},{"month":5,"riseRate":0.428571,"avgChangeRate":0.02344},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.13038},{"month":7,"riseRate":0.428571,"avgChangeRate":0.032629},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.18226},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.118561},{"month":10,"riseRate":0.571429,"avgChangeRate":0.001882},{"month":11,"riseRate":0.285714,"avgChangeRate":0.010198},{"month":12,"riseRate":0.428571,"avgChangeRate":0.146627}],"exchange":"NASDAQ","name":"Bioxcel Therapeutics Inc.","nameEN":"Bioxcel Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bioxcel Therapeutics Inc.(BTAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bioxcel Therapeutics Inc.,BTAI,Bioxcel Therapeutics Inc.股票,Bioxcel Therapeutics Inc.股票老虎,Bioxcel Therapeutics Inc.股票老虎国际,Bioxcel Therapeutics Inc.行情,Bioxcel Therapeutics Inc.股票行情,Bioxcel Therapeutics Inc.股价,Bioxcel Therapeutics Inc.股市,Bioxcel Therapeutics Inc.股票价格,Bioxcel Therapeutics Inc.股票交易,Bioxcel Therapeutics Inc.股票购买,Bioxcel Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bioxcel Therapeutics Inc.(BTAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}